Contact this trialFirst, we need to learn more about you.
VRG50635 for ALS
Recruiting1 awardPhase 1
Montreal, Quebec
This trial is testing a new drug called VRG50635 to see if it is safe for people with ALS, a disease that affects nerve cells. The main goal is to check if patients can tolerate the drug without serious side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service